Movement Alert|MEDBOT-B Intraday Decline 5.12%, Profit-Taking Follows Prior Sessions Earnings-Driven Surge Amid Sector Weakness

Market Focus07-24 10:47

On July 24, MEDBOT-B fell 5.12% in regular trading, trading at 19.94 HKD/share, with turnover of HKD 105 million. The decline comes after the stock surged over 10% in the prior session following a positive profit warning issued on July 22.

The company announced it expects to record its first-ever half-year net profit of RMB 28 million to RMB 40 million for the six months ended June 30, compared with a net loss of RMB 115 million in the year-ago period. Revenue is expected to grow approximately 200% to 230% year over year, driven by strong sales of its Toumai laparoscopic surgical robot, with overseas market revenue surging over 450%. Gross profit margin improved by more than 15 percentage points.

Despite the positive fundamentals, the broader Health Care Equipment sector is under pressure, with MICROPORT down 3.08%, LIFETECH SCI down 5.66%, AK MEDICAL down 2.85%, MICROPORT NEURO down 1.79%, and ANGELALIGN down 1.38%. Market participants have also noted ongoing selling pressure from recently approved full-circulation H-shares and competitive concerns regarding potential pricing moves by industry leader Intuitive Surgical.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment